Lek Xarelto, containing rivaroxaban, is one of the recently introduced prescription medications used to treat deep vein thrombosis (DVT) or pulmonary embolism (PE). This medicine is also used to prevent thrombosis in adults with artificial heart or hip joints and in patients with acute lymphoblastic leukemia (ALL).
The dosage of Xarelta depends on the type and type of treatment being used. For the treatment of deep vein thrombosis or pulmonary embolism, the recommended dose is 15-20mg once daily, taken orally. For the prevention of thrombosis due to an artificial heart or hip joints, the recommended dose is 10-20mg once daily taken orally. For patients with acute lymphoblastic leukemia, the recommended dose is 10 mg once daily taken orally. The drug should be taken regularly, without sacrificing yourself, to ensure optimal treatment.
Istnieją również potencjalne zamienniki leku Xarelto dostępne w Polsce. For example, the drug Warfarin (containing anticoagulants) it is used to treat DVT and PE. It is also used as antithrombotic prophylaxis in the case of an artificial heart. Lek Pradaxa (containing dabigatran) is used to treat DVT and PE, as well as in the prevention of thrombosis in adults with an artificial heart. Lek Eliquis (containing apixaban) is used to treat DVT and PE, as well as in the prevention of thrombosis in adults with an artificial heart.
In addition, there are other medications, which can be used as alternative or complementary solutions for patients with DVT and PE, including medicines containing heparin, heparin with thrombin and acetylsalicylic acid inhibitors.
Obecnie Xarelto i jego zamienniki są dostępne wyłącznie na receptę w Polsce. Before starting treatment, the patient must consult a doctor to determine the recommended dose, to make sure, that the medicine is being used correctly. Patients should also tell their doctor about all other medications they take, that they currently use, including herbal medicines, vitamins, supplements and other prescription or over-the-counter medications.